 LEEDS, England--BUSINESS WIRE--4D pharma plc AIM: DDD, NASDAQ: LBPS, a pharmaceutical company leading the development of Live Biotherapeutic products LBPs, a novel class of drug derived from the microbiome, today announces two poster presentations at the European Society for Medical Oncology ESMO Congress, held from September 16-21, 2021. The two e-posters will be available from 07:30 BST 02:30 ET on September 16, 2021. Poster presentation details are as follows: Presentation Title: 